Detalles de la búsqueda
1.
Sodium butyrate and monensin supplementation to postweaning heifer diets: Effects on growth performance, nutrient digestibility, and health.
J Dairy Sci
; 103(11): 10207-10218, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32952029
2.
Supplementation of sodium butyrate to postweaned heifer diets: Effects on growth performance, nutrient digestibility, and health.
J Dairy Sci
; 102(4): 3121-3130, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30738684
3.
Effects of supplemental butyrate and weaning on rumen fermentation in Holstein calves.
J Dairy Sci
; 102(10): 8874-8882, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31351719
4.
Infusion of butyrate affects plasma glucose, butyrate, and ß-hydroxybutyrate but not plasma insulin in lactating dairy cows.
J Dairy Sci
; 101(4): 3524-3536, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29409601
5.
Single-dose infusion of sodium butyrate, but not lactose, increases plasma ß-hydroxybutyrate and insulin in lactating dairy cows.
J Dairy Sci
; 100(1): 757-768, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27837980
6.
Salmonella enterica causes more severe inflammatory disease in C57/BL6 Nramp1G169 mice than Sv129S6 mice.
Vet Pathol
; 50(5): 867-76, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23446432
7.
COVID-19 mRNA vaccination and myocarditis/pericarditis in the setting of active surveillance at a military treatment facility.
BMJ Mil Health
; 2023 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37973371
8.
The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.
J Am Coll Cardiol
; 32(6): 1779-86, 1998 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-9822109
9.
Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms.
Mol Endocrinol
; 8(2): 148-58, 1994 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-8170471
10.
Antihypertensive effects of a novel endothelin-A receptor antagonist in rats.
Hypertension
; 25(6): 1191-5, 1995 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-7768562
11.
Synthesis and biological activity of novel calcium channel blockers: 2,5-dihydro-4-methyl-2-phenyl-1,5-benzothiazepine-3-carboxylic acid esters and 2,5-dihydro-4-methyl-2-phenyl-1,5-benzodiazepine-3-carboxylic acid esters.
J Med Chem
; 30(4): 635-40, 1987 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-2435903
12.
Dihydropyrimidine calcium channel blockers. 3. 3-Carbamoyl-4-aryl-1,2,3,4-tetrahydro-6-methyl-5-pyrimidinecarboxylic acid esters as orally effective antihypertensive agents.
J Med Chem
; 34(2): 806-11, 1991 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-1995904
13.
Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
J Med Chem
; 35(17): 3254-63, 1992 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-1387168
14.
Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers.
J Med Chem
; 31(5): 936-44, 1988 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-2834556
15.
Active conformation of 1,4-dihydropyridine calcium entry blockers. Effect of size of 2-aryl substituent on rotameric equilibria and receptor binding.
J Med Chem
; 34(8): 2521-4, 1991 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-1652021
16.
Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines.
J Med Chem
; 33(5): 1510-5, 1990 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-2329573
17.
Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.
J Med Chem
; 36(16): 2335-42, 1993 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-8360878
18.
Dihydropyrimidine angiotensin II receptor antagonists.
J Med Chem
; 35(25): 4751-63, 1992 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-1469703
19.
Benzazepinone calcium channel blockers. 5. Effects on antihypertensive activity associated with N1 and aromatic substituents.
J Med Chem
; 35(14): 2610-7, 1992 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-1635059
20.
Substituted 1,2,3,4-tetrahydroaminonaphthols: antihypertensive agents, calcium channel blockers, and adrenergic receptor blockers with catecholamine-depleting effects.
J Med Chem
; 30(4): 627-35, 1987 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-2435902